Latest News and Press Releases
Want to stay updated on the latest news?
-
PHILADELPHIA, April 28, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corp. (NASDAQ: IART): Current Integra LifeSciences Holdings Corp. (NASDAQ: IART) shareholders who have held the...
-
PHILADELPHIA, April 25, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corp. (NASDAQ: IART): Grabar Law Office is investigating whether the Board of Directors of Integra LifeSciences...
-
PHILADELPHIA, April 24, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) If you have held BioAge Labs, Inc. (NASDAQ: BIOA) shares continuously since on or shortly after its September 26,...
-
PHILADELPHIA, April 22, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) If you have held BioAge Labs, Inc. (NASDAQ: BIOA) shares continuously since on or shortly after its September 26,...
-
PHILADELPHIA, April 21, 2025 (GLOBE NEWSWIRE) -- Methode Electronics, Inc. (NYSE: MEI): Grabar Law Office is investigating claims on behalf of Methode Electronics Inc. (NYSE: MEI) shareholders. The...
-
PHILADELPHIA, April 17, 2025 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (NASDAQ: KYTX): Grabar Law Office is investigating claims on behalf of Kyverna Therapeutics, Inc. (NASDAQ: KYTX)...
-
PHILADELPHIA, April 17, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) If you have held BioAge Labs, Inc. (NASDAQ: BIOA) shares continuously since on or shortly after its September...
-
PHILADELPHIA, April 16, 2025 (GLOBE NEWSWIRE) -- Driven Brands Holdings, Inc. (NASDAQ: DRVN) Class Action Survives Motion to Dismiss: A securities fraud class action complaint against Driven...
-
PHILADELPHIA, April 14, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics Inc. (NASDAQ: AXSM) Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of...
-
PHILADELPHIA , April 11, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics Inc. (NASDAQ: AXSM) Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of...